Company intelligence
Acesion Pharma
Pioneering better treatments for atrial fibrillation.
Pharmaceutical Manufacturing
Copenhagen, DK
22 employees
Founded 2011
3 public signals
About Acesion Pharma
Acesion Pharma is a Danish biotech company founded in 2011. We are aiming to develop more efficacious and safer drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The scientific foundation of Acesion Pharma is the novel concept of treating AF by inhibiting SK ion channels.
Verified activity
Signals from Acesion Pharma
3 published signals
Presence & Recognition
Acesion Pharma investigators Me and Birgitte Vestbjerg attended the ESC 2026 meeting.
Reported by Acesion Pharma
Research & Knowledge
Acesion Pharma participated in the ongoing Phase 2 clinical trial of AP31969, a compound for rhythm control of atrial fibrillation.
Reported by Acesion Pharma
Presence & Recognition
Acesion Pharma returned from the 2026 European Society of Cardiology congress.
Reported by Acesion Pharma